"Life Science Industry Panel: New Frontiers of Precision Medicine," Moderator, AUTM 2017 Western Region Meeting, October 2017.
Precision medicine is changing the landscape of patient care. With the emergence of big data analytics and AI, development of novel therapies and how they are used to treat diseases has become increasingly precise. This session will focus on how companies are developing strategies to identify important disease biomarkers, stratify patient populations, and use that information to create more effective therapeutics. Industry representatives will describe both how data-driven analytics can be used to develop improved diagnostics and conversely, how biopharma can leverage that information to increase the chances of bringing a successful product to the market. The questions that we will seek to answer during this session are:
- How is a data-driven approach informing/altering traditional drug development?
- What technologies are companies with an interest in precision medicine seeking out?
- How is industry partnering with academia to advance precision medicine?
Thursday, October 12, 2017-
AUTM 2017 Western Region Meeting
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.